SHELBY RICHARDSON: Open Payments
NPI 1518593326 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,295 in 123 payments from 18 companies in 2025. Trend: 2023 $2,159 · 2024 $2,115 · 2025 $2,295
Food & beverage: $2,116Education: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $329 |
| UCB, Inc. | 12 | $321 |
| Janssen Biotech, Inc. | 24 | $305 |
| Incyte Corporation | 11 | $261 |
| Mallinckrodt Hospital Products Inc. | 9 | $251 |
| PFIZER INC. | 12 | $190 |
| Regeneron Healthcare Solutions, Inc. | 6 | $148 |
| GENZYME CORPORATION | 4 | $98 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $91 |
| Amgen Inc. | 1 | $66 |
Products named: Bimzelx, TREMFYA, OPZELURA, ACTHAR, DUPIXENT, CIBINQO, SKYRIZI, RINVOQ.
Industry payments across FL — which companies pay providers there.
